Today: 30 April 2026
P&G stock slides again after Wells Fargo cuts target — what investors watch next
6 January 2026
1 min read

P&G stock slides again after Wells Fargo cuts target — what investors watch next

NEW YORK, January 5, 2026, 21:15 EST — Market closed

  • Procter & Gamble shares fell about 1% on Monday, extending a five-session slide.
  • Wells Fargo cut its price target to $158 from $170 while keeping an Overweight rating.
  • Next catalysts include U.S. jobs data (Jan. 9) and P&G’s quarterly results (Jan. 22).

Procter & Gamble (PG.N) shares ended down about 1% on Monday at $140.37 after Wells Fargo cut its price target to $158 from $170 and kept an Overweight rating on the stock.

The move marked P&G’s fifth straight daily decline and left the stock about 22% below its 52-week high. Trading volume was about 12.1 million shares, above its 50-day average of 9.6 million.

The slide came on a strong day for the broader market, with the S&P 500 up 0.64% and the Dow up 1.23%. P&G also moved largely in step with parts of the defensive complex, with Johnson & Johnson and Colgate-Palmolive also lower.

Rate expectations are back in focus in early January, and that matters for steady cash-flow names such as P&G. “What keeps us awake at night is that inflation risk has resurfaced,” Julius Bendikas, European head of economics and dynamic asset allocation at Mercer, told Reuters. Reuters

Wells Fargo’s price-target cut brings its view to roughly 13% above Monday’s close, but P&G is still trading near the lower end of its 52-week range, with a low of $138.14. A price target is an analyst’s estimate of where a stock could trade over the next year; “Overweight” signals a preference versus peers in that coverage universe. marketwatch.com+1

Macro data in the coming sessions could move bond yields and shift the market’s appetite for defensive shares. The December U.S. employment report is due on January 9, followed by December CPI on January 13, according to the Labor Department’s release calendar.

The Federal Reserve’s next policy meeting is scheduled for January 27-28, a focal point for equity valuations as investors debate how quickly rate cuts can resume.

Company-specific attention turns to P&G’s quarterly results, where investors typically look for updates on pricing versus volumes, input-cost trends, and any changes to management’s outlook. The stock’s recent drift toward its 52-week low has also put technical support in view around the high-$130s.

But the set-up cuts both ways: if results show weaker demand, heavier promotions, or margin pressure, P&G risks breaking below support levels and slipping further out of favor as investors rotate toward faster-growing corners of the market.

P&G is scheduled to report fiscal second-quarter earnings on January 22 and host a conference call at 8:30 a.m. ET.

Stock Market Today

  • KONE Oyj Shares Show Weakness, Valuation Analysis Signals Overvaluation
    April 30, 2026, 8:50 AM EDT. KONE Oyj's share price dropped 4.6% last week and 1.7% last month, despite a 3% gain over the past year. The company, a key player in global elevators and escalators, faces scrutiny as infrastructure demand impacts investor sentiment. Our Discounted Cash Flow (DCF) model projects an intrinsic value of €47.26 per share, indicating the current price of €54.46 is roughly 15.2% overvalued. The firm scores 0/6 on valuation checks, raising red flags for potential investors. The Price-to-Earnings (P/E) ratio, another metric for assessing stock value tied to earnings, also factors into ongoing valuation debates. The mixed returns across 1, 3, and 5 years heighten questions about KONE's long-term investment appeal amid market uncertainty.

Latest article

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

30 April 2026
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market had bottomed and highlighted progress in data-center chips. Fiscal Q2 revenue fell 3% to $10.6 billion, with handset revenue down 13% but automotive up 38%. The Q3 forecast missed Wall Street estimates. Qualcomm expects chip sales to Chinese handset makers to recover after Q3.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Caterpillar stock jumps: what CAT plans to unveil with Nvidia at CES 2026
Previous Story

Caterpillar stock jumps: what CAT plans to unveil with Nvidia at CES 2026

UK rail disruption: Whitehaven replacement buses suspended as Blackburn points failure delays Northern trains
Next Story

UK rail disruption: Whitehaven replacement buses suspended as Blackburn points failure delays Northern trains

Go toTop